IRIS
ROSSI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.715
AS - Asia 3.070
EU - Europa 2.907
SA - Sud America 410
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 11.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.618
CN - Cina 1.691
IE - Irlanda 701
SG - Singapore 651
RU - Federazione Russa 392
DE - Germania 374
HK - Hong Kong 358
FI - Finlandia 353
BR - Brasile 342
UA - Ucraina 329
IT - Italia 254
VN - Vietnam 156
GB - Regno Unito 154
SE - Svezia 129
FR - Francia 57
BE - Belgio 53
CA - Canada 51
IN - India 44
MX - Messico 35
JP - Giappone 28
BD - Bangladesh 27
AR - Argentina 25
PL - Polonia 25
TR - Turchia 20
AT - Austria 15
CZ - Repubblica Ceca 13
ES - Italia 13
NL - Olanda 13
MA - Marocco 12
ID - Indonesia 11
IQ - Iraq 11
CO - Colombia 10
EC - Ecuador 10
IR - Iran 10
PK - Pakistan 10
ZA - Sudafrica 10
LT - Lituania 7
AL - Albania 6
BO - Bolivia 5
CL - Cile 5
EG - Egitto 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
BY - Bielorussia 3
EU - Europa 3
GR - Grecia 3
KE - Kenya 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
SR - Suriname 2
TM - Turkmenistan 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
YE - Yemen 1
Totale 11.153
Salva come PNG Salva come JPEG
Città #
Dublin 700
Chandler 657
Dallas 556
Beijing 406
Jacksonville 383
Hong Kong 358
Singapore 351
Ashburn 337
Nanjing 323
San Jose 322
Ann Arbor 235
Boardman 180
Munich 133
Los Angeles 131
Nanchang 127
Helsinki 120
Princeton 111
Lawrence 109
Shenyang 105
Wilmington 99
Changsha 97
Medford 95
Hebei 81
New York 80
Shanghai 73
Pavia 67
Moscow 63
Jiaxing 62
Woodbridge 62
Tianjin 60
Hangzhou 58
Turku 57
Ho Chi Minh City 54
Brussels 52
Milan 48
Buffalo 46
Redondo Beach 44
São Paulo 40
Hanoi 32
Verona 27
Houston 24
Tokyo 23
Washington 23
Orem 21
San Francisco 21
Warsaw 21
Chicago 19
Seattle 19
Dearborn 18
Montreal 18
Brooklyn 17
Denver 17
Falkenstein 17
Santa Clara 16
Toronto 16
Auburn Hills 15
Frankfurt am Main 15
London 15
Stockholm 15
Atlanta 14
Fairfield 14
Norwalk 14
Poplar 14
Rio de Janeiro 14
The Dalles 14
Chennai 13
Nuremberg 13
Ankara 12
Kunming 12
Belo Horizonte 11
Boston 11
San Giuliano Milanese 11
Guangzhou 10
Jinan 10
Rome 10
Vigevano 9
Des Moines 8
Ningbo 8
Vienna 8
Brasília 7
Buenos Aires 7
Dhaka 7
Johannesburg 7
Mexico City 7
Phoenix 7
Zhengzhou 7
Baghdad 6
Brno 6
Charlotte 6
Falls Church 6
Haiphong 6
Olomouc 6
Piscataway 6
Vancouver 6
Can Tho 5
Columbus 5
Da Nang 5
Manchester 5
Mumbai 5
Ninh Bình 5
Totale 7.648
Salva come PNG Salva come JPEG
Nome #
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 164
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 160
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 159
Adesion proteins in CHO cells. 153
Cartilage histogenesis in a murine model of chondrodysplasia 144
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 142
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 140
A novel splicing mutation causes an undescribed type of analbuminemia. 140
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 138
A Mn(II)-Mn(II) center in human prolidase 134
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 131
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 129
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 129
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 127
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion. 125
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 124
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 124
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 124
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 123
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 120
Comparative analysis of the expression of methionine sulfoxide reductase enzymes in human blood cells 119
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 118
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 117
Methionine sulfoxide reductase enzymes (Msr): a comparative analysis of the levels of expression in human blood cells 116
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 116
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 114
Alteration of proteoglycan sulfation affects bone growth and remodeling. 114
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 114
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 114
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 113
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 112
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. 112
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 112
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 111
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 109
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 109
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 108
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 108
Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations 108
Lack of prolidase causes a bone phenotype both in human and in mouse 108
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 107
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 105
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 105
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 104
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 104
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 104
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 103
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 103
Ultrastructural aspects of cartilage histogenesis in a model of chondrodysplasia 103
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia 101
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 100
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 100
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 100
A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations 99
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 99
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 99
Novel nonsense mutation causes analbuminemia in a Moroccan family. 98
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 98
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 97
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 95
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. 95
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica 95
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 94
Stability of type I collagen peptide trimers. 94
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 91
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 90
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 89
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 88
Mucosal expression of the receptor for the advanced glycation end products (RAGE) in patients with inflammatory bowel disease (IBD) 88
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 87
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 87
Achondrogenesis type 1B is caused by mutations in the diastrophic dysplasia sulfate transporter gene 86
Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view 86
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and collagen expression in the exostoses. 84
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity 83
Type I collagen CNBr peptides: species and behavior in solution 81
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 80
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 79
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 79
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 78
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes 78
Skeletal Dysplasias Caused by Sulfation Defects 78
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 78
Analysis of proteoglycan synthesis and secretion in cell culture systems 77
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 76
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 75
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 73
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 72
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 70
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 70
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 70
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. 69
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. 69
FGF signalling regulates bone growth through autophagy 69
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 69
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 69
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes and diagnostic relevance. 68
New dysplasia or achondrogenesis type 1 B? The importance of histology and molecular biology in delineating skeletal dysplasias. 68
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 67
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features 67
Totale 10.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 0 13 102 29 91 82 19
2021/2022528 12 10 14 13 13 9 13 40 21 18 87 278
2022/20231.871 180 175 15 151 194 165 6 88 804 20 46 27
2023/2024664 90 141 25 48 63 155 15 40 9 24 28 26
2024/20252.095 54 133 61 61 84 92 88 99 542 62 297 522
2025/20263.104 363 536 560 492 529 225 399 0 0 0 0 0
Totale 11.362